TY - JOUR
T1 - Screening for rheumatoid arthritis-associated interstitial lung disease-a Delphi-based consensus statement
AU - Hackner, Klaus
AU - Hütter, Lisa
AU - Flick, Holger
AU - Grohs, Michael
AU - Kastrati, Kastriot
AU - Kiener, Hans
AU - Lang, David
AU - Mosheimer-Feistritzer, Birgit
AU - Prosch, Helmut
AU - Rath, Eva
AU - Schindler, Otmar
AU - Moazedi-Fürst, Florentine
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/2/14
Y1 - 2025/2/14
N2 - OBJECTIVE: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a major driver of premature mortality in patients with rheumatoid arthritis (RA). Detection of RA-ILD is crucial but requires awareness among the treating physicians. To date, however, there is no international recommendation concerning screening for ILD in RA patients.METHODS: After a systematic literature review, the modified Delphi technique in combination with the nominal group technique was used to provide a Delphi consensus statement elaborated by an expert panel of pneumonologists, rheumatologists, and a radiologist. Based on the available evidence, several clusters of questions were defined and discussed until consent was reached.RESULTS: A screening algorithm for ILD in patients with RA based on clinical signs, respiratory symptoms, and risk factors has been developed. Further, the recommendations address diagnostic tools for RA-ILD and the follow-up of RA patients qualifying for ILD screening.
AB - OBJECTIVE: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a major driver of premature mortality in patients with rheumatoid arthritis (RA). Detection of RA-ILD is crucial but requires awareness among the treating physicians. To date, however, there is no international recommendation concerning screening for ILD in RA patients.METHODS: After a systematic literature review, the modified Delphi technique in combination with the nominal group technique was used to provide a Delphi consensus statement elaborated by an expert panel of pneumonologists, rheumatologists, and a radiologist. Based on the available evidence, several clusters of questions were defined and discussed until consent was reached.RESULTS: A screening algorithm for ILD in patients with RA based on clinical signs, respiratory symptoms, and risk factors has been developed. Further, the recommendations address diagnostic tools for RA-ILD and the follow-up of RA patients qualifying for ILD screening.
KW - Antifibrotic agents
KW - Autoimmune diseases
KW - Fibrosis
KW - Mass screening
KW - Risk factors
KW - Arthritis, Rheumatoid/complications
KW - Lung Diseases, Interstitial/diagnosis
KW - Humans
KW - Risk Factors
UR - http://www.scopus.com/inward/record.url?scp=86000427782&partnerID=8YFLogxK
U2 - 10.1007/s10405-025-00604-0
DO - 10.1007/s10405-025-00604-0
M3 - Journal article
SN - 1613-5636
VL - 22
SP - 87
EP - 92
JO - Zeitschrift fur Pneumologie
JF - Zeitschrift fur Pneumologie
IS - 2
ER -